Degrado, William
- University of California, San Francisco · Internal Medicine (NIH department code)
From the FY2018 NIH awards this investigator leads as contact PI. The department is the award's.
FY2018 NIH rank #4,245
- Sustained Excellence
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2012 through FY2018Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2018 award categories
- Internal Medicine
NIH Funding · FY2018
Linked Award Amount
$1.5M
Full award amounts, FY2018
Award Records
1
Records listing this PI
Award-Linked Rank
#4,245
By linked amount among FY2018 PIs
Earliest Year Loaded
2012
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2018 award records by amount
NIH award records listing Degrado, William as a PI. Multi-PI records show the full award amount for context.
- 5UH3HL123423-05UH3Contact PITreatment of pulmonary fibrosis with inhibitors of integrin alphavbeta1.University of California, San Francisco · Internal Medicine (NIH department code)$1.5Maward amount
Award organization
Organizations that administered FY2018 awards listing Degrado, William as a PI.
FY2018 award administered by University of California, San Francisco (CA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2012First NIH AwardUniversity of California, San Francisco
- 2012$500K Cumulative Funding
- 2013$1M Cumulative Funding
- 2014$2M Cumulative Funding
- 2014Entered Top 50% NationallyRanked #3286
- 2014Entered Top 25% NationallyRanked #3286
- 2016$5M Cumulative Funding